Exploration of Management Model and Intervention Research on Fear of Cancer Recurrence

Launched by NANFANG HOSPITAL, SOUTHERN MEDICAL UNIVERSITY · Jun 24, 2023

Keywords

ClinConnect Summary

This clinical trial is focused on understanding and managing the fear of cancer recurrence in patients who have been diagnosed with cancer. Researchers aim to identify factors that contribute to this fear and develop a model to help screen patients who may be at a higher risk of experiencing intense anxiety about their cancer coming back. They will also conduct a study to evaluate how mindfulness and stress reduction techniques can help ease this fear for patients who are struggling with it.

To participate in this trial, individuals must be at least 18 years old, have a confirmed diagnosis of cancer, and be comfortable using smartphones or computers. Participants will be asked to provide consent and follow study protocols. This trial is not yet recruiting participants, but it aims to provide valuable insights into better ways to support cancer patients in managing their fears, ultimately improving their quality of life during and after treatment.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults aged ≥ 18 years old
• • Consistent with pathological diagnosis of cancer
• • Able to understand and comply with research protocols
• • Written informed consent can be provided
• • Own and know how to use smart ·terminals (such as smartphones, tablets, computers, etc.)
• Exclusion Criteria:
• • Patients with mental illness and consciousness disorders;
• • Patients with cancer metastasis or recurrence
• • End of life treatment for patients.